Management of rheumatic chorea: an observational study
Arq. neuropsiquiatr
; 60(2A): 231-233, June 2002. tab
Article
em En
| LILACS
| ID: lil-309214
Biblioteca responsável:
BR1.1
RESUMO
BACKGROUND:
Rheumatic chorea (RC) has recently been linked to an antibody-mediated immune mechanism. OBJECTIVE/METHOD:
To verify if this knowledge reflected in management changes we conceived a descriptive study.RESULTS:
The medical charts of 20 children (13 females) aged 6 to 12 years (mean 8 years), diagnosed as RC from June 1996 to June 1999, were reviewed. All patients received some medical treatment. Haloperidol was the most prescribed medication (15 patients - 75 percent). Sulpiride, diazepam and valproate were also used as symptomatic treatment. Imune-modulating therapy with prednisone was prescribed for seven children. The shortest course of chorea (16 days) occurred in a patient treated with prednisone.CONCLUSION:
Prednisone has been prescribed for rheumatic chorea besides the traditional symptomatic approach. A great variety of antichoreic drugs are being employed
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Coreia
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Child
/
Female
/
Humans
Idioma:
En
Revista:
Arq. neuropsiquiatr
Assunto da revista:
NEUROLOGIA
/
PSIQUIATRIA
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Brasil